Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

The Effect of Aging on Tissues

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Is Embolization a Safe Treatment Option for Certain Traumatic Subdural Hematomas?

Kansas journal of medicine·2026

Same author

A Retrospective Study on the Use of Robotic Surgery in Rural Areas Compared to Urban Centers.

The American surgeon·2026

Same author

Unintentional Firearm-Related Injury and Death at a Level 1 Trauma Center Located in a Rural State.

The American surgeon·2026

Same author

Time To Tighten Up on Prehospital Tourniquets: An EAST Multicenter Trial of Prehospital Procedures in Penetrating Trauma Shows No Benefit With Current Tourniquet Practices for Extremity Trauma in Urban Settings.

The American surgeon·2025

Same author

Evaluation of Resident Participation on Specimen Margin Status in Patients Undergoing Lumpectomy.

The American surgeon·2025

Same author

Moderate- to High-grade Blunt Liver and Spleen Injuries Warrant Repeat Imaging to Identify Treatable Complications: Results of the Radiographic Evaluation of Delayed Solid Organ Complications EAST Multicenter Trial.

Annals of surgery·2025

Search research articles

Related Experiment Video

Updated: Oct 4, 2025

A Test Bed to Examine Helmet Fit and Retention and Biomechanical Measures of Head and Neck Injury in Simulated Impact

A Test Bed to Examine Helmet Fit and Retention and Biomechanical Measures of Head and Neck Injury in Simulated Impact

Published on: September 21, 2017

Octogenarian Motor Vehicle Collisions: Injury Patterns Matter.

Michael L Lemon¹, Stephen D Helmer¹, Kathryn Sobba¹

¹Department of Surgery, University of Kansas School of Medicine-Wichita, Wichita, KS.

Kansas Journal of Medicine

|February 2, 2022

Summary

Motor vehicle collisions (MVCs) pose a significant risk to octogenarians, with mortality linked to injury severity and in-hospital complications, not prior health conditions. This highlights the need for targeted interventions for older adults after MVCs.

Keywords:

comorbidity mortality octogenarian polypharmacy traffic accidents

More Related Videos

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults

Published on: November 7, 2014

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights

Published on: October 25, 2024

Related Experiment Videos

Last Updated: Oct 4, 2025

A Test Bed to Examine Helmet Fit and Retention and Biomechanical Measures of Head and Neck Injury in Simulated Impact

A Test Bed to Examine Helmet Fit and Retention and Biomechanical Measures of Head and Neck Injury in Simulated Impact

Published on: September 21, 2017

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults

Published on: November 7, 2014

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights

Published on: October 25, 2024

Area of Science:

Trauma surgery
Geriatric medicine
Public health

Background:

Motor vehicle collisions (MVCs) are a leading cause of injury in octogenarians.
This demographic exhibits higher-than-expected mortality rates following trauma.
Factors influencing outcomes in elderly trauma patients require investigation.

Purpose of the Study:

To examine factors influencing mortality in octogenarians injured in MVCs.
To identify predictors of adverse outcomes in this vulnerable population.
To differentiate between pre-existing conditions and injury-related factors affecting mortality.

Main Methods:

Retrospective review of 239 patients aged 80+ involved in MVCs over 10 years.
Data collection included demographics, comorbidities, medications, injury details, and hospital interventions.
Analysis correlated patient factors and interventions with mortality outcomes.

Main Results:

Overall mortality rate was 18.8% among octogenarian MVC patients.
Increased mortality was associated with severe injury patterns, rural settings, blood transfusion, intubation, and ICU admission.
No significant correlation was found between mortality and pre-existing comorbidities or medications.

Conclusions:

Mortality in octogenarians post-MVC is primarily driven by injury severity and in-hospital complications.
Pre-existing comorbidities and medications did not significantly correlate with increased mortality.
Focusing on injury management and critical care interventions is crucial for improving outcomes.